Clinical Trial Update: NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair [Phase 1, Phase 2]

View source ↗

Summary

Preliminary clinical trial update for NeuroRegen Scaffold combined with stem cells in chronic spinal cord injury; phase 1/2 study with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• NeuroRegen Scaffold
• Stem cells (mesenchymal stem cells)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Spinal Cord Injury | Phase 1, Phase 2 | Status: UNKNOWN